May 19, 2026 12:07PM
May 11, 2026 08:30AM
May 6, 2026 06:30AM
Mar 25, 2026 07:59AM
Mar 25, 2026 07:59AM
Mar 5, 2026 08:31AM
Mar 5, 2026 08:30AM PacBio Announces the Appointment of Chris Gibson to the Board of Directors
Feb 25, 2026 06:30AM
Dec 8, 2025 07:30AM
Dec 8, 2025 07:30AM
Dec 8, 2025 07:30AM
Dec 8, 2025 07:30AM
Nov 18, 2025 08:45AM
Sep 8, 2025 07:01AM Biodexa enrolls first patients in Phase 3 trial for FAP treatment
Jul 28, 2025 07:00AM
Jun 4, 2025 02:36PM
May 4, 2025 12:45PM
Apr 29, 2025 08:45AM
Apr 22, 2025 08:34PM
Mar 18, 2025 08:03AM
Mar 18, 2025 08:00AM Recursion Bolsters Board of Directors with Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun
Feb 5, 2025 05:27PM
Feb 5, 2025 05:24PM
Jan 7, 2025 09:15AM
Jan 7, 2025 09:15AM
Jan 7, 2025 09:15AM
Dec 4, 2024 08:45AM
Nov 6, 2024 04:15PM Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results
Oct 2, 2024 02:17PM
Oct 2, 2024 08:02AM
Oct 2, 2024 08:00AM
Sep 3, 2024 03:00PM
Sep 3, 2024 02:54PM
Sep 3, 2024 11:50AM
Sep 3, 2024 08:19AM Recursion Pharmaceuticals (RXRX) Declines 7% Following Phase 2 Data of REC-994
Sep 3, 2024 08:00AM
Sep 3, 2024 08:00AM
Aug 8, 2023 07:58AM
Jun 13, 2023 08:00AM
Sep 13, 2022 07:59AM
Aug 9, 2022 04:15PM
Jul 21, 2022 07:55AM Recursion Pharmaceuticals (RXRX) Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis
Jul 21, 2022 07:55AM
Jun 20, 2022 07:55AM
May 10, 2022 04:29PM
Apr 11, 2022 07:55AM
Apr 11, 2022 07:55AM
Mar 23, 2022 07:55AM
Mar 23, 2022 07:55AM Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2021 Financial Results
Mar 18, 2022 07:55AM

323,555 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All